Alzheimer's Disease — Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
Citation(s)
An Open-label Extension to Study AVA105640, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.